Related Experiment Video
Updated: Oct 7, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast
1Department of Growth and Development, Program in Cell Biology, University of California at San Francisco, San Francisco, CA 94143-0640, USA.
Abstract:
Transforming growth factor-beta (TGF-beta), a secreted factor present at high levels in bone, inhibits osteoblast differentiation in culture; yet, the mechanism of this inhibition remains unclear. We studied the effects of TGF-beta and its effectors, the Smads, on the expression and function of the osteoblast transcription factor CBFA1. TGF-beta inhibited the expression of the cbfa1 and osteocalcin genes, whose expression is controlled by CBFA1 in osteoblast-like cell lines. This inhibition was mediated by Smad3, which interacts physically with CBFA1 and represses its transcriptional activity at the CBFA1-binding OSE2 promoter sequence. The repression of CBFA1 function by Smad3 contrasts with previous observations that Smads function as transcription activators. This repression occurred in mesenchymal but not epithelial cells, and depended on the promoter sequence. Smad3-mediated repression of CBFA1 provides a central regulatory mechanism for the inhibition of osteoblast differentiation by TGF-beta, since it inhibits both cbfa1 transcription and transcriptional activation of osteoblast differentiation genes by CBFA1. Altering Smad3 signaling influenced osteoblast differentiation in the presence or absence of TGF-beta, implicating Smad3/TGF-beta-mediated repression in autocrine regulation of osteoblast differentiation.
Insights
Transforming growth factor-beta (TGF-beta) inhibits osteoblast differentiation by Smad3 repressing the transcription factor CBFA1. This Smad3-mediated repression of CBFA1 activity is crucial for TGF-beta
Area of Science:
- Bone biology
- Cell signaling
- Molecular mechanisms
Background:
- Transforming growth factor-beta (TGF-beta) is abundant in bone and inhibits osteoblast differentiation.
- The precise mechanism by which TGF-beta exerts this inhibitory effect is not fully understood.
Purpose of the Study:
- To investigate the effects of TGF-beta and Smad proteins on the expression and function of the osteoblast transcription factor CBFA1.
- To elucidate the molecular mechanisms underlying TGF-beta-induced inhibition of osteoblast differentiation.
Main Methods:
- Studied the impact of TGF-beta on cbfa1 and osteocalcin gene expression in osteoblast-like cell lines.
- Investigated the physical interaction and functional consequences of Smad3 binding to CBFA1.
- Analyzed the effect of Smad3 on CBFA1 transcriptional activity at the OSE2 promoter sequence.
- Examined the role of Smad3 signaling in osteoblast differentiation under varying TGF-beta conditions.
Main Results:
- TGF-beta inhibited the expression of cbfa1 and osteocalcin genes.
- Smad3 physically interacted with CBFA1 and repressed its transcriptional activity.
- This repression occurred specifically at the OSE2 promoter sequence in mesenchymal cells.
- Smad3-mediated repression of CBFA1 was found to be critical for TGF-beta's inhibition of osteoblast differentiation.
- Modulation of Smad3 signaling affected osteoblast differentiation, suggesting its role in autocrine regulation.
Conclusions:
- Smad3-mediated repression of CBFA1 is a key mechanism for TGF-beta's inhibition of osteoblast differentiation.
- This pathway regulates both cbfa1 gene transcription and CBFA1's activation of osteoblast-specific genes.
- Smad3 signaling plays a significant role in the autocrine regulation of osteoblast differentiation by TGF-beta.
Related Concept Videos
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Master Transcription Regulators
General Transcription Factors
